Search for: "Dow Chemical Co., Inc." Results 161 - 180 of 191
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Jun 2021, 12:29 pm by admin
There is one less force of nature in the universe. [read post]
10 Feb 2010, 12:49 am
DOJ Continues Fight for Deloitte Records The National Law Journal The Justice Department wants to convince a federal appeals court in Washington, D.C., that the accounting firm Deloitte should be forced to give up tax documents stemming from auditing services provided to Dow Chemical Co. [read post]
26 Jul 2010, 9:08 am by Steven M. Taber
– Department of Justice News Release, July 22, 2010 Champion Chemical Company, Imperial Oil Company Inc. and Imperial’s two former officers have agreed to pay at least $1.4 million to resolve actions to enforce a prior agreement to reimburse cleanup costs incurred by the federal government at the Imperial Oil Company Inc. [read post]
6 Apr 2016, 12:06 pm by W.F. Casey Ebsary, Jr.
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), General Electric Co. v. [read post]
30 May 2008, 9:09 am
: (IP ThinkTank), (further discussion from IAM and e^(ip)) Illusory world of trade secret protection – Discussion of S Schreter’s article ‘Inside entrepreneurship: Patent protection isn’t only option’: (IPBiz)   Global – Copyright Illegal art: (Patry Copyright Blog),     Events 1-3 June: ACC Europe 2008 annual conference ‘Becoming a global legal manager: Developing the skills you will need to manage the… [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
9 Jul 2017, 10:21 am by Schachtman
When the defendants, such as Dow Corning, reacted by sponsoring serious epidemiologic analyses of the issue whether exposure to silicone gel was associated with specific autoimmune or connective tissue diseases, the plaintiffs’ bar mounted a conflict-of-interest witch hunt over industry funding.6 Ultimately, the source of funding became obviously irrelevant; the concordance between industry-funded and all high quality research on the litigation claims was undeniable. [read post]
1 Jan 2023, 4:00 am by Administrator
Doxtator’s case separately from that of the co-accused. [read post]
28 Dec 2017, 2:18 pm by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
29 May 2015, 2:24 pm by John Elwood
John Elwood reviews Tuesday’s relisted cases. [read post]
9 May 2007, 1:34 pm
Dow Chemical Co., 273 F.3d 249 (2d Cir. 2001), aff'd by equally divided court, 539 U.S. 111 (2003). [read post]
14 Feb 2009, 11:56 am
This post is by my colleagues Gail Lees, Andrew Tulumello, Chip Nierlich, Mark Whitburn and Chris Chorba. [read post]